Roche is now expanding its product portfolio with Eversense, a continuous glucose monitoring (CGM) system from Senseonics (Maryland, US).
Roche struck a deal for exclusive distribution of Senseonics’ technology in Germany, Italy and the Netherlands – with the option to extend to other European countries.
Roche will also be responsible for sales, marketing and customer support, while Senseonics retains responsibility for product development and manufacturing.
Eversense is Senseonics’ first diabetes management system, and includes a small sensor, a smart transmitter and a mobile App.
Another example of the needle-free trend in glucose monitoring,